INTEGRATED BIOPHARMA INC (INBP) Revenue 2016–2025
INTEGRATED BIOPHARMA INC (INBP) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$54.4MFY2025 · since FY2016: $42.2M → $54.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $54.4M | +8.0% |
| FY2024 | $50.3M | -0.7% |
| FY2023 | $50.7M | -9.9% |
| FY2022 | $56.2M | -11.5% |
| FY2021 | $63.6M | +20.4% |
| FY2020 | $52.8M | +5.6% |
| FY2019 | $50.0M | +14.3% |
| FY2018 | $43.7M | -6.9% |
| FY2017 | $47.0M | +11.2% |
| FY2016 | $42.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice